Hospital/country | Patients receiving esmolol (n) | Wait 24 hb | Peak infusion rates (μg/kg/min)a | Esmolol mortality (%) | Use of non-adrenergic inotropes | RCTd |
---|---|---|---|---|---|---|
Intermountain/USA | 7 | No | 50 (25–50) | 0 | No | No |
La Sapienza/Italy [23] | 77 | Yes | 22 (11–66) | 49 | Yes | Yes |
La Sapienza/Italy [22] | 26 | Yes | 55 (22–233) | NAc | Likelyc | No |
La Sapienza/Italy [44] | 45 | Yes | NAc | 51 | Likelyc | No |
Prague/Czech Rep [49] | 10 | No | 61 ± 20 | 10 | No | No |
Peking Union/China [54] | 63 | No | 25 ± 20 | 8 | No | No |
Jiangxi/China [53] | 30 | No | NAc | 40 | Yes | Yes |